Research Article On Alzheimer's Disease

0830
from research organizations

Recent Alzheimer's & Dementia Articles. Generation of a human induced pluripotent stem cell–based model for tauopathies combining three microtubule-associated protein tau mutations which displays several phenotypes linked to neurodegeneration. For the last two decades, the focus of most Alzheimer’s research has been on a disease model called “the amyloid hypothesis,” which begins with the “amyloid beta” precursor protein (APP.

Date:
June 12, 2019
Source:
University of South Florida (USF Innovation)
Summary:
Apolipoproten E (apoeE) is a major genetic risk factor for the development of Alzheimer's disease, yet it tends to be understudied as a potential druggable target for the mind-robbing neurodegenerative disease. Now a research team reports that a novel apoE antagonist blocks apoE interaction with N-terminal amyloid precursor protein (APP) and reduces hallmark Alzheimer's-associated pathologies.
Share:

Apolipoproten E (apoeE) is a major genetic risk factor for the development of Alzheimer's disease, yet the protein tends to be understudied as a potential druggable target for the mind-robbing neurodegenerative disease.

Now a research team led by the University of South Florida Health (USF Health) Morsani College of Medicine reports that a novel apoE antagonist blocks apoE interaction with N-terminal amyloid precursor protein (APP). Moreover, this peptide antagonist, known as 6KApoEp, was shown to reduce Alzheimer's-associated beta amyloid (β-amyloid) accumulation and tau pathologies in the brain, as well as improving learning and memory in mice genetically engineered to mimic symptoms of Alzheimer's disease.

Recent Research Articles On Alzheimer's Disease Pdf

Many failed anti-amyloid therapies for Alzheimer's disease have been directed against various forms of the protein β-amyloid, which ultimately forms clumps of sticky plaques in the brain. The presence of these amyloid plaques is one of the major hallmarks of Alzheimer's disease.

The USF Health research findings suggests that disrupting apoE physical interaction with N-terminal APP may be a new disease-modifying therapeutic strategy for this most common type of dementia.

The preclinical study was published online May 2 in Biological Psychiatry.

'For the first time, we have direct evidence that the N-terminal section of apoE itself acts as an essential molecule (ligand) to promote the binding of apoeE to the N-terminal region of APP outside the nerve cell,' said the study's lead author Darrell Sawmiller, PhD, an assistant professor in the USF Health Department of Psychiatry & Behavioral Neurosciences. 'This receptor-mediated mechanism plays a role in the development of Alzheimer's disease. Overstimulation of APP by apoE may be an earlier, upstream event that signals other neurodegenerative processes contributing to the amyloid cascade.'

'Initially we wanted to better understand how apoE pathologically interacts with APP, which leads to the formation of β-amyloid plaques and neuronal loss,' said study senior author Jun Tan, PhD, MD, a professor in the USF Health Department of Psychiatry & Behavioral Neurosciences. 'Our work further discovered an apoE derivative that can modulate structural and functional neuropathology in Alzheimer's disease mouse models.'

Research

Story Source:

#10434 - Used 2002 Delta 3HGN 3 Horse Trailer with 4' Short Wall. #30456 - Used 2000 Featherlite 7404GN 4 Horse Trailer with 5' Short Wall. View nationwide listing of new and used horse trailers. ON SALE NOW NEW ELITE 4 HORSE REVERSE LOAD 16'8' LQ SLIDE OUT - COUCH AND WRAP. Used 4 horse trailers for sale in texas.

Materials provided by University of South Florida (USF Innovation). Note: Content may be edited for style and length.

Scholarly Articles On Alzheimer's Disease

Journal Reference:

  1. Darrell Sawmiller, Ahsan Habib, Huayan Hou, Takashi Mori, Anran Fan, Jun Tian, Jin Zeng, Brian Giunta, Paul R. Sanberg, Mark P. Mattson, Jun Tan. A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition. Biological Psychiatry, 2019; DOI: 10.1016/j.biopsych.2019.04.026

Cite This Page:

University of South Florida (USF Innovation). 'Potential new therapeutic target for Alzheimer's disease.' ScienceDaily. ScienceDaily, 12 June 2019. <www.sciencedaily.com/releases/2019/06/190612141409.htm>.
University of South Florida (USF Innovation). (2019, June 12). Potential new therapeutic target for Alzheimer's disease. ScienceDaily. Retrieved July 7, 2019 from www.sciencedaily.com/releases/2019/06/190612141409.htm
University of South Florida (USF Innovation). 'Potential new therapeutic target for Alzheimer's disease.' ScienceDaily. www.sciencedaily.com/releases/2019/06/190612141409.htm (accessed July 7, 2019).

  • RELATED TERMS
    • Alzheimer's disease
    • Dementia with Lewy bodies
    • Personalized medicine
    • Excitotoxicity and cell damage
    • Bovine spongiform encephalopathy
    • Urinary incontinence
    • Parkinson's disease
    • Amyloid
Research
Antibody Removes Alzheimer's Plaques, in Mice
Research article on alzheimer
Mar. 26, 2018 — Plaques of a brain protein called amyloid beta are a characteristic sign of Alzheimer's disease. But nestled within the plaques are small amounts of another Alzheimer's protein: APOE. Now, .. read more
Alzheimer's Damage in Mice Reduced With Compound That Targets APOE Gene
Dec. 6, 2017 — People who carry the APOE4 genetic variant face a substantial risk for developing Alzheimer's disease. Now, researchers have identified a compound that targets the APOE protein in the brains of mice .. read more
Alzheimer Research: New Findings
Nov. 16, 2015 — Current Alzheimer's research focuses on the amyloid precursor protein (APP), which is responsible for the formation of destructive plaques in the brain. Researchers have now demonstrated that APP, in .. read more

Alzheimer's Disease Articles Pdf

New Genetic Risk Marker for Late-Life Depression
Nov. 3, 2015 — One of the most powerful predictors in neuropsychiatry is the epsilon 4 (?4) allele of the apolipoprotein gene (APOE). Individuals who carry this ?4 variant of APOE are at increased risk for .. read more
Below are relevant articles that may interest you. ScienceDaily shares links with scholarly publications in the TrendMD network and earns revenue from third-party advertisers, where indicated.
This entry was posted on 30.08.2019.